Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Upcoming SlideShare
Loading in …5
×

Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies

234 views

Published on

Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification TechnologiesSummaryGBI Research's report, 'Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies', provides the key data and analyzes the major challenges and drivers for the downstream industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the downstream processing of biopharmaceuticals. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical and biotech industry. The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts to provide a comprehensive view of the Down Stream Processing in Biopharmaceuticals.ScopeThe scope of this report includes: - Opportunities and challenges for manufacturers of Biopharmaceuticals in the pharmaceuticals industry - Market revenues and forecasts for Down Stream Processing in the global pharmaceutical industry from 2009 to 2016. - The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China. - Downstream bioprocess involves detailed technological development and possible development in near future. - Technology trends in downstream bioprocess that shape the biomanufacturing industry - Qualitative analysis of the market drivers, barriers, future outlook and challenges for the downstream bioprocess.- Analysis of competitive landscape and the leading market players.Reasons to buy- Formulate strategies to increase your company's growth by understanding the new growth opportunities in the downstream market.- Work around the technology hurdles by identifying the key trends shaping and driving the market for downstream bioprocess. - Differentiate yourself from competitors and develop new solutions for the biomanufacturing industry by understanding the current competitive landscape and how it is evolving to meet the increasing demands - Draft efficient strategies by understanding best practices, identifying key winners and losers and who is best positioned to take advantage of the emerging market opportunities

  • Be the first to comment

  • Be the first to like this

Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Downstream Processing in Biopharmaceuticals - Increased Demandfor Biologics Drives Improvement in Cost -effective PurificationTechnologiesPublished on November 2010 Report SummaryDownstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective PurificationTechnologiesSummaryGBI Researchs report, Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement inCost-effective Purification Technologies, provides the key data and analyzes the major challenges and drivers for the downstreamindustry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the downstream processingof biopharmaceuticals. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in thepharmaceutical and biotech industry. The report is based on proprietary databases, primary and secondary research and in-houseanalysis by GBI Researchs team of industry experts to provide a comprehensive view of the Down Stream Processing inBiopharmaceuticals.ScopeThe scope of this report includes:- Opportunities and challenges for manufacturers of Biopharmaceuticals in the pharmaceuticals industry- Market revenues and forecasts for Down Stream Processing in the global pharmaceutical industry from 2009 to 2016.- The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China.- Downstream bioprocess involves detailed technological development and possible development in near future.- Technology trends in downstream bioprocess that shape the biomanufacturing industry- Qualitative analysis of the market drivers, barriers, future outlook and challenges for the downstream bioprocess.- Analysis of competitive landscape and the leading market players.Reasons to buy- Formulate strategies to increase your companys growth by understanding the new growth opportunities in the downstream market.- Work around the technology hurdles by identifying the key trends shaping and driving the market for downstream bioprocess.- Differentiate yourself from competitors and develop new solutions for the biomanufacturing industry by understanding the currentcompetitive landscape and how it is evolving to meet the increasing demands- Draft efficient strategies by understanding best practices, identifying key winners and losers and who is best positioned to takeadvantage of the emerging market opportunities Table of ContentDownstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies (From Slideshare) Page 1/7
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!1 Table of Contents 31.1 List of Tables 51.2 List of Figures 62 Downstream Processing: Introduction 82.1 GBI Research Report Guidance 83 Downstream Processing Market Overview 93.1 Overview of Biopharmaceuticals 93.1.1 Cytokines 93.1.2 Enzymes 93.1.3 Hormones 93.1.4 Clotting Factors 93.1.5 Vaccines 103.1.6 Monoclonal Antibodies 103.1.7 Cell Therapies 103.1.8 Antisense Drugs 103.1.9 Peptide Therapeutics 103.2 Overview of Downstream Processing in Biopharmaceuticals 123.2.1 A Typical Downstream Processing: 133.2.2 Major Check Point during Down Stream Processing 143.3 Overview of Downstream Industry 154 Downstream Processing : Role of Downstream Processing in the Biopharmaceutical Industry 164.1 Comparison of Upstream Processing and Downstream Processing 184.2 Major Reagents, Reagent Suppliers and Reagent Market Related To Downstream Processing 194.2.1 Major Reagents 194.2.2 Reagent Suppliers 204.2.3 Reagent Market 224.3 Major Equipment Suppliers 265 Downstream Processing: Downstream Processing Market for CMOs 275.1 Global CMO Market Overview 275.2 CMO Biopharmaceuticals Market Characterization 275.3 CMO Market Size for Downstream Processing 296 Downstream Processing : Challenges and Unmet Needs in Downstream Bioprocess 306.1 Challenges 306.1.1 Chromatographic Capture 306.1.2 Reducing the Purification Steps 306.1.3 Titer increment /Capacity Bottleneck 316.1.4 Virus Clearances 316.1.5 Scaling Up 316.2 Unmet Needs 326.2.1 Unmet Medical Needs 326.2.2 Realistic Achievement of Economies of Scale 336.2.3 Technological Development of Disposables at Large Scale 346.2.4 Reagent Cost and Their Effectiveness 357 Downstream Processing : Emerging Technologies and their Implication 367.1 Disposable Technology / Single Use Technology 367.1.1 Use of Single Use Technology in Downstream Operations 397.1.2 Major Benefits of Single use Technology 407.1.3 Major Challenges in Single Use Technology 41Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies (From Slideshare) Page 2/7
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!7.1.4 Some Recent Products Developed By Major Firms 427.2 Membrane Chromatography 427.3 Multi-Column Chromatography 447.3.1 Advantages 447.3.2 Drawbacks 447.3.3 Applications 457.4 Aqueous Two Phase System 457.5 Tangential Flow Filtration 457.5.1 Tangential Flow Filtration Applications 467.5.2 Few Products Developed By Major Firms 477.6 Monoliths 477.7 Expanded-Bed Adsorption (EBA) Chromatography 477.7.1 Applications 487.8 Mixed-Mode Chromatography 488 Downstream Processing : Industry Analysis 508.1 Key Drivers and Restraints 508.1.1 Key Drivers of Downstream Processing Market 508.1.2 Key Restraints of Downstream Processing Market 518.2 Porter Five Forces Model for Industry Analysis 528.3 Impact of Environmental Factors on the Industry 558.3.1 International Economy Impact 558.3.2 The Natural Environment Impact 558.3.3 Technological Impact 558.3.4 Political or Governmental Impact 558.3.5 Demographic Structure 568.3.6 Social Structure 568.4 Major Events and Their Impact Analysis 569 Downstream Processing: Competitive Landscape 579.1 Market Dynamics of Downstream Processing and Impact 579.1.1 Market Structure 579.1.2 Competitive Analysis of Major CMO Firms 589.1.3 Competitive Analysis of Equipment and Reagent Industry 599.2 Key Equipment Players 609.2.1 Pall Corporation 609.2.2 Milipore 639.2.3 Sartorius 669.2.4 3M Purification Inc. 699.3 Key Reagent Players 719.3.1 Life Technologies 719.3.2 Sigma Aldrich 749.3.3 SWOT Analysis 759.3.4 M&A Deals 759.4 Key CMO Players 779.4.1 Lonza 779.4.2 Boehringer Ingelheim 809.4.3 SWOT Analysis 819.4.4 Avecia Biotechnology 839.4.5 Diosynth Biotechnology 85Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies (From Slideshare) Page 3/7
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!10 Downstream Processing : Appendix 8810.1 Market Definitions 8810.2 Abbreviations 8810.3 Research Methodology 8910.3.1 Coverage 8910.3.2 Secondary Research 8910.3.3 Primary Research 8910.3.4 Expert Panel Validation 9010.4 Contact Us 9010.5 Disclaimer 9010.6 Sources 911.1 List of TablesTable 1: Downstream Processing, Comparison of Upstream and Downstream Process, 2009 18Table 2: Downstream Processing, Reagent Suppliers, 2009 21Table 3: Downstream Processing, Comparison of Mammalian and Microbial Culture, 2009 23Table 4: Downstream Processing, Equipment Suppliers, 2009 26Table 5: Downstream Processing, Types of Single Use Technologies and Vendors, 2009 38Table 6: Downstream Processing, Key Equipment Players, Pall Corporation, Major M&A Deals, 2005-2009 62Table 7: Downstream Processing, Key Equipment Players, Milipore, Major M&A Deals, 2005-2009 65Table 8: Downstream Processing, Key Equipment Players, Sartorius, Major M&A Deals, 2005-2009 68Table 9: Downstream Processing, Key Equipment Players, 3M, Major M&A Deals, 2005-2009 70Table 10: Downstream Processing, Key Reagent Players, Life Technologies, Major M&A Deals, 2005-2009 73Table 11: Downstream Processing, Key Reagent Players, Sigma Aldrich, Major M&A Deals, 2005-2009 76Table 12: Downstream Processing, Key CMO Players, Lonza, Major M&A Deals, 2005-2009 79Table 13: Downstream Processing, Key CMO Players, Boehringer Ingelhiem, Major M&A Deals, 2005-2009 82Table 14: Downstream Processing, Key Players, Avecia, Major M&A Deals, 2004-2009 85Table 15: Downstream Processing, Key CMO Players, Diosynth Biotechnology, Major M&A Deals, 2005-09 871.2 List of FiguresFigure 1: Downstream Processing, Biopharmaceutical Types, 2009 9Figure 2: Downstream Processing, Overview of General Drug Development Process, 2009 12Figure 3: Downstream Processing, Technologies Employed Along with Steps, 2009 13Figure 4: Downstream Processing, Changing Distribution of Cost along with Yield Increment, 2009 16Figure 5: Downstream Processing, Yield Percentage v/s Number of Purification Steps, 2009 17Figure 6: Downstream Processing, Cost Breakups of Upstream and Downstream Process, 2009 18Figure 7: Downstream Processing, Total Reagent Market for Downstream Processing, Revenue ($m), 2009-2016 22Figure 8: Downstream Processing, CMOs Reagent Market for Mammalian Capacity, Revenue ($m) 2009-2016 23Figure 9: Downstream Processing, CMOs Reagent Market for Microbial Capacity, Revenue ($m) 2009-2016 24Figure 10: Downstream Processing, In-house Reagent Market for Mammalian Capacity, Revenue ($m) 2009-2016 25Figure 11: Downstream Processing, In-house Reagent Market for Microbial Capacity, Revenue ($m) 2009-2016 25Figure 12: Downstream Processing, CMO Biopharmaceutical Market, Revenue ($bn), 2007-2016 28Figure 13: Downstream Processing, Downstream Process Market For CMOs, Revenue ($bn), 2007-2016 29Figure 14: Downstream Processing, Challenges, 2009 30Figure 15: Downstream Processing, Unmet Medical Needs, 2009 32Figure 16: Downstream Processing, Unmet Achievement of Economies of Scale, 2009 33Figure 17: Downstream Processing, Unmet Technological Advancement, 2009 34Figure 18: Downstream Processing, Unmet Reagent Cost Structure, 2009 35Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies (From Slideshare) Page 4/7
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Figure 19: Downstream Processing, Emerging Technologies and their Likely Adaptation, 2009 36Figure 20: Downstream Processing, Single Use Technologies Benefits, 2009 40Figure 21: Downstream Processing, Single Use Technologies Challenges, 2009 41Figure 22: Downstream Processing, Industry Analysis, Key Drivers and Restraints, 2009 51Figure 23: Downstream Processing, Industry Analysis, Porter Five Forces Model, 2009 52Figure 24: Downstream Processing, Industry Analysis, Environmental Factors and Impact, 2009 55Figure 25: Downstream Processing, Industry Analysis, Major Market Events and their Impact, 2009 56Figure 26: Downstream Processing, Industry Analysis, Market Dynamics, 2009 58Figure 27: Downstream Processing, Industry Analysis, Competitive Analysis of Major CMOs, 2009 58Figure 28: Downstream Processing, Industry Analysis, Competitive Analysis of Major Equipment / Reagent Players, 2009 59Figure 29: Downstream Processing, Key Equipment Players, Business Overview, Pall Corporation, 2009 60Figure 30: Downstream Processing, Key Equipment Players, SWOT Analysis, Pall Corporation, 2009 61Figure 31: Downstream Processing, Key Equipment Players, Business Overview, Milipore, 2009 63Figure 32: Downstream Processing, Key Equipment Players, SWOT Analysis, Milipore, 2009 64Figure 33: Downstream Processing, Key Equipment Players, Business Overview, Sartorius, 2009 66Figure 34: Downstream Processing, Key Equipment Players, SWOT Analysis, Sartorius, 2009 67Figure 35: Downstream Processing, Key Equipment Players, Business Overview, 3M Purification Inc. , 2009 69Figure 36: Downstream Processing, Key Equipment Players, SWOT Analysis, 3M Purification Inc. , 2009 70Figure 37: Downstream Processing, Key Reagent Players, Business Overview, Life Technologies, 2009 71Figure 38: Downstream Processing, Key Reagent Players, SWOT Analysis, Life Technologies, 2009 72Figure 39: Downstream Processing, Key Reagent Players, Business Overview, Sigma-Aldrich, 2009 74Figure 40: Downstream Processing, Key Reagent Players, SWOT Analysis, Sigma-Aldrich, 2009 75Figure 41: Downstream Processing, Key CMO Players, Business Overview, Lonza, 2009 77Figure 42: Downstream Processing, Key CMO Players, SWOT Analysis, Lonza, 2009 78Figure 43: Downstream Processing, Key CMO Players, Business Overview, Boehringer Ingelheim, 2009 80Figure 44: Downstream Processing, Key CMO Players, SWOT Analysis, Boehringer Ingelheim, 2009 81Figure 45: Downstream Processing, Key CMO Players, Business Overview, Avecia , 2009 83Figure 46: Downstream Processing, Key CMO Players, SWOT Analysis, Avecia, 2009 84Figure 47: Downstream Processing, Key CMO Players, Business Overview, Diosynth Biotechnology, 2009 86Figure 48: Downstream Processing, Key CMO Players, SWOT Analysis, Diosynth Biotechnology, 2009 87Companies mentionedPall CorporationMiliporeSartorius3M Purification Inc.Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies (From Slideshare) Page 5/7
  6. 6. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effec tive Purification Technologies Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 500.00 Quantity: _____ Site License--USD 7 000.00 Quantity: _____ Corporate License--USD 10 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies (From Slideshare) Page 6/7
  7. 7. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies (From Slideshare) Page 7/7

×